Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Free Subscription

Articles published in PLoS One

Retrieve available abstracts of 112 articles:
HTML format

Single Articles

    January 2024
  1. PALACIOS A, Espinola N, Gonzalez JM, Rojas-Roque C, et al
    Budget impact analysis of venetoclax for the management of acute myeloid leukemia from the perspective of the social security and the private sector in Argentina.
    PLoS One. 2024;19:e0295798.
    PubMed     Abstract available

  2. HUANG T, Leung B, Huang Y, Price L, et al
    A murine model to evaluate immunotherapy effectiveness for human Fanconi anemia-mutated acute myeloid leukemia.
    PLoS One. 2024;19:e0292375.
    PubMed     Abstract available

  3. HIRASAWA I, Odagiri H, Park G, Sanghavi R, et al
    Correction: Anti-inflammatory effects of cold atmospheric plasma irradiation on the THP-1 human acute monocytic leukemia cell line.
    PLoS One. 2024;19:e0299329.
    PubMed     Abstract available

  4. KANITTHAMNIYOM C, Wannaphut C, Pattanaprichakul P, Kungwankiattichi S, et al
    Organomegalies as a predictive indicator of leukemia cutis in patients with acute myeloid leukemia.
    PLoS One. 2024;19:e0297805.
    PubMed     Abstract available

  5. SWANSON AJ, Rogowski VJ, Bishop JA, Walker DM, et al
    CLEC11A methylation is correlated to AML subtypes and cytogenetic risk factors but not patient demographics.
    PLoS One. 2024;19:e0300477.
    PubMed     Abstract available

  6. SUN K, Tian X, Xia J, Li Q, et al
    Promoting leisure functions through setting creative linguistic landscapes in recreational zones.
    PLoS One. 2024;19:e0299775.
    PubMed     Abstract available

  7. Retraction: Sensitive Detection of Pre-Existing BCR-ABL Kinase Domain Mutations in CD34+ Cells of Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia Patients Is Associated with Imatinib Resistance: Implications in the Post-Imatinib Era.
    PLoS One. 2024;19:e0301946.

  8. MESSLING JE, Pena-Romer I, Moroni AS, Bruestl S, et al
    RIO-kinase 2 is essential for hematopoiesis.
    PLoS One. 2024;19:e0300623.
    PubMed     Abstract available

  9. KNOPPERS T, Haley CE, Bouhouita-Guermech S, Hagan J, et al
    From code to care: Clinician and researcher perspectives on an optimal therapeutic web portal for acute myeloid leukemia.
    PLoS One. 2024;19:e0302156.
    PubMed     Abstract available

  10. EISSENBERG LG, Ritchey JK, Rettig MP, Patel DA, et al
    Control of acute myeloid leukemia and generation of immune memory in vivo using AMV564, a bivalent bispecific CD33 x CD3 T cell engager.
    PLoS One. 2024;19:e0300174.
    PubMed     Abstract available

  11. MURAKAMI K, Matsunaga T, Matsuzaki T, Naruke Y, et al
    Serum bta-miRNA-375 as a potential biomarker for the early diagnosis of enzootic bovine leukosis.
    PLoS One. 2024;19:e0302868.
    PubMed     Abstract available

  12. DONG L, Dai G, Zhao J
    Impact of body mass index at diagnosis on outcomes of pediatric acute leukemia: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0302879.
    PubMed     Abstract available

  13. SUZUKI S, Suzuki S, Sato-Nagaoka Y, Ito C, et al
    Identification of triciribine as a novel myeloid cell differentiation inducer.
    PLoS One. 2024;19:e0303428.
    PubMed     Abstract available

  14. HAN HJ, Choi K, Suh HS
    Impact of aging on acute myeloid leukemia epidemiology and survival outcomes: A real-world, population-based longitudinal cohort study.
    PLoS One. 2024;19:e0300637.
    PubMed     Abstract available

    January 2023
  15. MAEZAWA M, Fujii Y, Akagami M, Kawakami J, et al
    Phylogenetic analysis based on whole genome sequence of bovine leukemia virus in cattle under 3 years old with enzootic bovine leukosis.
    PLoS One. 2023;18:e0279756.
    PubMed     Abstract available

  16. PETERSEN MI, Carignano HA, Mongini C, Gonzalez DD, et al
    Bovine leukemia virus encoded blv-miR-b4-3p microRNA is associated with reduced expression of anti-oncogenic gene in vivo.
    PLoS One. 2023;18:e0281317.
    PubMed     Abstract available

  17. SAWAISORN P, Atjanasuppat K, Uaesoontrachoon K, Rattananon P, et al
    Comparison of the efficacy of second and third generation lentiviral vector transduced CAR CD19 T cells for use in the treatment of acute lymphoblastic leukemia both in vitro and in vivo models.
    PLoS One. 2023;18:e0281735.
    PubMed     Abstract available

  18. VERGIER J, Reynaud R, Michel G, Auquier P, et al
    Misconceptions and beliefs around hormone replacement therapy after childhood hematopoietic stem cell transplantation: A qualitative study among women leukemia survivors.
    PLoS One. 2023;18:e0283940.
    PubMed     Abstract available

  19. LI K, Wang H, Yang C, Li C, et al
    Clinical implication and potential function of ARHGEF6 in acute myeloid leukemia: An in vitro study.
    PLoS One. 2023;18:e0283934.
    PubMed     Abstract available

  20. PANG JM, Chien PC, Kao MC, Chiu PY, et al
    MicroRNA-708 emerges as a potential candidate to target undruggable NRAS.
    PLoS One. 2023;18:e0284744.
    PubMed     Abstract available

  21. YOON K, Shin CM, Han K, Jung JH, et al
    Risk of cancer in patients with insomnia: Nationwide retrospective cohort study (2009-2018).
    PLoS One. 2023;18:e0284494.
    PubMed     Abstract available

  22. MITROVSKY O, Myslivcova D, Machackova-Lopotova T, Obr A, et al
    Inhibition of casein kinase 2 induces cell death in tyrosine kinase inhibitor resistant chronic myelogenous leukemia cells.
    PLoS One. 2023;18:e0284876.
    PubMed     Abstract available

  23. ALVARADO ORTIZ M, Suarez Ramos T, Torres Cintron CR, Zavala Zegarra D, et al
    Racial/ethnic disparities for leukemias in Puerto Rico and the United States of America, 2015-2019.
    PLoS One. 2023;18:e0285547.
    PubMed     Abstract available

  24. RATTANATHAMMETHEE T, Munsamai K, Punnachet T, Hantrakun N, et al
    D-index and invasive fungal infections (IFIs) in adult acute myeloid leukemia (AML) patients with the first episode of febrile neutropenia.
    PLoS One. 2023;18:e0286089.
    PubMed     Abstract available

  25. LI Q, Chen Y, Zhao X, Lu B, et al
    Ginsenoside 24-OH-PD from red ginseng inhibits acute T-lymphocytic leukaemia by activating the mitochondrial pathway.
    PLoS One. 2023;18:e0285966.
    PubMed     Abstract available

  26. ALI AM, Adam H, Hailu D, Coenen MJH, et al
    Incidence and determinants of hematotoxicity in acute lymphoblastic leukemia children who received 6-mercaptopurine based maintenance therapy in Addis Ababa, Ethiopia.
    PLoS One. 2023;18:e0286544.
    PubMed     Abstract available

  27. SCHNUCHEL A, Radcke C, Theobald L, Doeding S, et al
    Quality comparison of a state-of-the-art preparation of a recombinant L-asparaginase derived from Escherichia coli with an alternative asparaginase product.
    PLoS One. 2023;18:e0285948.
    PubMed     Abstract available

  28. MANSOUR RSH, Al Khawaja AY, Hamdan II, Khalil EA, et al
    IR microspectroscopic investigation of the interaction of some losartan salts with human stratum corneum protein and its effect on losartan transdermal permeation.
    PLoS One. 2023;18:e0287267.
    PubMed     Abstract available

  29. AL-KHATIB SM, Ababneh O, Abushukair H, Abdo N, et al
    The impact of IDH and NAT2 gene polymorphisms in acute myeloid leukemia risk and overall survival in an Arab population: A case-control study.
    PLoS One. 2023;18:e0289014.
    PubMed     Abstract available

  30. DEHGHANI FIROUZABADI F, Gopal N, Hasani A, Homayounieh F, et al
    CT radiomics for differentiating fat poor angiomyolipoma from clear cell renal cell carcinoma: Systematic review and meta-analysis.
    PLoS One. 2023;18:e0287299.
    PubMed     Abstract available

  31. HUYEN NT, Ngoc NT, Giang NH, Trang DT, et al
    CYLD stimulates macrophage phagocytosis of leukemic cells through STAT1 signalling in acute myeloid leukemia.
    PLoS One. 2023;18:e0283586.
    PubMed     Abstract available

  32. HUANG Z, Shen Y, Fan X, Guo Q, et al
    Yinzhihuang injection induces apoptosis and suppresses tumor growth in acute myeloid leukemia cells.
    PLoS One. 2023;18:e0289697.
    PubMed     Abstract available

  33. ILYAS M, Aamir KM, Manzoor S, Deriche M, et al
    Linear programming based computational technique for leukemia classification using gene expression profile.
    PLoS One. 2023;18:e0292172.
    PubMed     Abstract available

  34. HIRASAWA I, Odagiri H, Park G, Sanghavi R, et al
    Anti-inflammatory effects of cold atmospheric plasma irradiation on the THP-1 human acute monocytic leukemia cell line.
    PLoS One. 2023;18:e0292267.
    PubMed     Abstract available

  35. POOPAK A, Saeedi Moghaddam S, Esfahani Z, Keykhaei M, et al
    National and subnational burden of leukemia and its risk factors, 1990-2019: Results from the Global Burden of Disease study 2019.
    PLoS One. 2023;18:e0287917.
    PubMed     Abstract available

  36. WANG Y, Travers RJ, Farrell A, Lu Q, et al
    Differential vascular endothelial cell toxicity of established and novel BCR-ABL tyrosine kinase inhibitors.
    PLoS One. 2023;18:e0294438.
    PubMed     Abstract available

  37. SWAIN RM, Sanchez A, Gutierrez DA, Varela-Ramirez A, et al
    Thiophene derivative inflicts cytotoxicity via an intrinsic apoptotic pathway on human acute lymphoblastic leukemia cells.
    PLoS One. 2023;18:e0295441.
    PubMed     Abstract available

    January 2022
  38. COLUNGA-LOZANO LE, Kenji Nampo F, Agarwal A, Desai P, et al
    Less intensive antileukemic therapies (monotherapy and/or combination) for older adults with acute myeloid leukemia who are not candidates for intensive antileukemic therapy: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0263240.
    PubMed     Abstract available

  39. HARVEY MJ, Zhong Y, Morris E, Beverage JN, et al
    Assessing the transition from intravenous to subcutaneous delivery of rituximab: Benefits for payers, health care professionals, and patients with lymphoma.
    PLoS One. 2022;17:e0261336.
    PubMed     Abstract available

  40. HUANG HH, Chen CM, Wang CY, Hsu WW, et al
    The epidemiology, treatment patterns, healthcare utilizations and costs of Acute Myeloid Leukaemia (AML) in Taiwan.
    PLoS One. 2022;17:e0261871.
    PubMed     Abstract available

  41. HOWELL DA, McCaughan D, Smith AG, Patmore R, et al
    Incurable but treatable: Understanding, uncertainty and impact in chronic blood cancers-A qualitative study from the UK's Haematological Malignancy Research Network.
    PLoS One. 2022;17:e0263672.
    PubMed     Abstract available

  42. ZAREI GHOBADI M, Emamzadeh R
    Integration of gene co-expression analysis and multi-class SVM specifies the functional players involved in determining the fate of HTLV-1 infection toward the development of cancer (ATLL) or neurological disorder (HAM/TSP).
    PLoS One. 2022;17:e0262739.
    PubMed     Abstract available

  43. ASHOTI A, Limone F, van Kranenburg M, Alemany A, et al
    Considerations and practical implications of performing a phenotypic CRISPR/Cas survival screen.
    PLoS One. 2022;17:e0263262.
    PubMed     Abstract available

  44. NORTHGRAVES M, Allsup D, Cohen J, Huang C, et al
    A prospective registry-based cohort study of the diagnosis and management of acute leukaemia in pregnancy: Study protocol.
    PLoS One. 2022;17:e0263195.
    PubMed     Abstract available

  45. SAJIKI Y, Konnai S, Okagawa T, Maekawa N, et al
    Estradiol-induced immune suppression via prostaglandin E2 during parturition in bovine leukemia virus-infected cattle.
    PLoS One. 2022;17:e0263660.
    PubMed     Abstract available

  46. SHELTON DN, Bhagavatula P, Sepulveda N, Beppu L, et al
    Performance characteristics of the first Food and Drug Administration (FDA)-cleared digital droplet PCR (ddPCR) assay for BCR::ABL1 monitoring in chronic myelogenous leukemia.
    PLoS One. 2022;17:e0265278.
    PubMed     Abstract available

  47. KUBO H, Imataki O, Kubo YH, Uemura M, et al
    c-D-index at day 11 can predict febrile neutropenia during chemotherapy in acute myeloid leukemia.
    PLoS One. 2022;17:e0263623.
    PubMed     Abstract available

  48. VAZQUEZ-CORNEJO E, Morales-Rios O, Hernandez-Pliego G, Cicero-Oneto C, et al
    Incidence, severity, and preventability of adverse events during the induction of patients with acute lymphoblastic leukemia in a tertiary care pediatric hospital in Mexico.
    PLoS One. 2022;17:e0265450.
    PubMed     Abstract available

  49. CESARO E, Falanga AP, Catapano R, Greco F, et al
    Exploring a peptide nucleic acid-based antisense approach for CD5 targeting in chronic lymphocytic leukemia.
    PLoS One. 2022;17:e0266090.
    PubMed     Abstract available

  50. SZCZESNIAK PP, Heidelberger JB, Serve H, Beli P, et al
    VCP inhibition induces an unfolded protein response and apoptosis in human acute myeloid leukemia cells.
    PLoS One. 2022;17:e0266478.
    PubMed     Abstract available

  51. PARE A, Ellis A, Juette T
    Clinicopathological findings of FeLV- positive cats at a secondary referral center in Florida, USA (2008-2019).
    PLoS One. 2022;17:e0266621.
    PubMed     Abstract available

  52. PEARSON S, Whetton AD, Pierce A
    Combination of curaxin and tyrosine kinase inhibitors display enhanced killing of primitive Chronic Myeloid Leukaemia cells.
    PLoS One. 2022;17:e0266298.
    PubMed     Abstract available

  53. MOPIN A, Lepretre F, Sebda S, Villenet C, et al
    Detection of residual and chemoresistant leukemic cells in an immune-competent mouse model of acute myeloid leukemia: Potential for unravelling their interactions with immunity.
    PLoS One. 2022;17:e0267508.
    PubMed     Abstract available

  54. MATOU-NASRI S, Najdi M, AlSaud NA, Alhaidan Y, et al
    Blockade of p38 MAPK overcomes AML stem cell line KG1a resistance to 5-Fluorouridine and the impact on miRNA profiling.
    PLoS One. 2022;17:e0267855.
    PubMed     Abstract available

  55. YAMAMOTO N, Kikuchi J, Furukawa Y, Shibayama N, et al
    Fast in-vitro screening of FLT3-ITD inhibitors using silkworm-baculovirus protein expression system.
    PLoS One. 2022;17:e0261699.
    PubMed     Abstract available

  56. HIRANO S, Udagawa O
    Effects of arsenic on the topology and solubility of promyelocytic leukemia (PML)-nuclear bodies.
    PLoS One. 2022;17:e0268835.
    PubMed     Abstract available

  57. HERNANDEZ VA, Carvajal-Moreno J, Wang X, Pietrzak M, et al
    Use of CRISPR/Cas9 with homology-directed repair to silence the human topoisomerase IIalpha intron-19 5' splice site: Generation of etoposide resistance in human leukemia K562 cells.
    PLoS One. 2022;17:e0265794.
    PubMed     Abstract available

  58. SIAMAKPOUR-REIHANI S, Cao F, Lyu J, Ren Y, et al
    Evaluating immune response and metabolic related biomarkers pre-allogenic hematopoietic stem cell transplant in acute myeloid leukemia.
    PLoS One. 2022;17:e0268963.
    PubMed     Abstract available

  59. GARNIASIH D, Susanah S, Sribudiani Y, Hilmanto D, et al
    The incidence and mortality of childhood acute lymphoblastic leukemia in Indonesia: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0269706.
    PubMed     Abstract available

  60. VIJAYVARGIYA P, Feri A, Mairey M, Rouillon C, et al
    Metagenomic shotgun sequencing of blood to identify bacteria and viruses in leukemic febrile neutropenia.
    PLoS One. 2022;17:e0269405.
    PubMed     Abstract available

  61. LIISBORG C, Skov V, Kjaer L, Hasselbalch HC, et al
    Lower CXCR3 expression in both patients with neovascular AMD and advanced stages of chronic myeloproliferative blood cancers.
    PLoS One. 2022;17:e0269960.
    PubMed     Abstract available

  62. BORODIN AM, Emanuilova ZV, Smolov SV, Ogneva OA, et al
    Eradication of avian leukosis virus subgroups J and K in broiler cross chickens by selection against infected birds using multilocus PCR.
    PLoS One. 2022;17:e0269525.
    PubMed     Abstract available

  63. FODIL S, Chevret S, Rouzaud C, Valade S, et al
    Post-remission outcomes in AML patients with high hyperleukocytosis and inaugural life-threatening complications.
    PLoS One. 2022;17:e0270744.
    PubMed     Abstract available

  64. FLO M, Carrion F, Olivero-Deibe N, Bianchi S, et al
    Kinetics of Bovine leukemia virus aspartic protease reveals its dimerization and conformational change.
    PLoS One. 2022;17:e0271671.
    PubMed     Abstract available

  65. BULTUM LE, Tolossa GB, Lee D
    Combining empirical knowledge, in silico molecular docking and ADMET profiling to identify therapeutic phytochemicals from Brucea antidysentrica for acute myeloid leukemia.
    PLoS One. 2022;17:e0270050.
    PubMed     Abstract available

  66. DONG K, Heidari M, Mays J, Chang S, et al
    A comprehensive analysis of avian lymphoid leukosis-like lymphoma transcriptomes including identification of LncRNAs and the expression profiles.
    PLoS One. 2022;17:e0272557.
    PubMed     Abstract available

  67. YOO J, Cho HS, Yoon JH, Cho BS, et al
    Risk stratification by 30-day prognostic factors of clinical outcomes after granulocyte transfusion in acute myeloid leukemia: A single-center retrospective study.
    PLoS One. 2022;17:e0273827.
    PubMed     Abstract available

  68. MIKHAYLENKO N, Wahnschaffe L, Herling M, Roeder I, et al
    Computational gene expression analysis reveals distinct molecular subgroups of T-cell prolymphocytic leukemia.
    PLoS One. 2022;17:e0274463.
    PubMed     Abstract available

  69. MOSQUERA ORGUEIRA A, Peleteiro Raindo A, Cid Lopez M, Antelo Rodriguez B, et al
    Correction: Gene expression profiling identifies FLT3 mutation-like cases in wild-type FLT3 acute myeloid leukemia.
    PLoS One. 2022;17:e0274984.
    PubMed     Abstract available

  70. KONGTA R, Panyasit N, Jansaento W, Duangmano S, et al
    Development of E-ice-COLD-PCR assay combined with HRM analysis for Nucleophosmin1 gene mutation detection in acute myelogenous leukemia.
    PLoS One. 2022;17:e0274034.
    PubMed     Abstract available

  71. DEERING KL, Sundaram M, Harshaw Q, Trudeau J, et al
    Health-related quality of life and treatment satisfaction in Chronic Lymphocytic Leukemia (CLL) patients on ibrutinib compared to other CLL treatments in a real-world US cross sectional study.
    PLoS One. 2022;17:e0270291.
    PubMed     Abstract available

  72. MALETZKE S, Salimi A, Vieri M, Schroeder KM, et al
    Combined inhibition of BCR-ABL1 and the proteasome as a potential novel therapeutic approach in BCR-ABL positive acute lymphoblastic leukemia.
    PLoS One. 2022;17:e0268352.
    PubMed     Abstract available

  73. SZELEST M, Masternak M, Zajac M, Chojnacki M, et al
    The role of NPM1 alternative splicing in patients with chronic lymphocytic leukemia.
    PLoS One. 2022;17:e0276674.
    PubMed     Abstract available

  74. CHEN Y, Wu T, Yang C, Lu M, et al
    A pyridinesulfonamide derivative FD268 suppresses cell proliferation and induces apoptosis via inhibiting PI3K pathway in acute myeloid leukemia.
    PLoS One. 2022;17:e0277893.
    PubMed     Abstract available

  75. HAO Q, Foroutan F, Han MA, Devji T, et al
    Prognosis of older patients with newly diagnosed AML undergoing antileukemic therapy: A systematic review.
    PLoS One. 2022;17:e0278578.
    PubMed     Abstract available

  76. DELLA PIA A, Kim GYG, Ip A, Ahn J, et al
    Anti-spike antibody response to the COVID vaccine in lymphoma patients.
    PLoS One. 2022;17:e0266584.
    PubMed     Abstract available

  77. SHAHID AM, Um IH, Elshani M, Zhang Y, et al
    NUC-7738 regulates beta-catenin signalling resulting in reduced proliferation and self-renewal of AML cells.
    PLoS One. 2022;17:e0278209.
    PubMed     Abstract available

    January 2021
  78. ELENS I, Deprez S, Billiet T, Sleurs C, et al
    Methylene tetrahydrofolate reductase A1298C polymorphisms influence the adult sequelae of chemotherapy in childhood-leukemia survivors.
    PLoS One. 2021;16:e0250228.
    PubMed     Abstract available

  79. YOO KH, Kim HJ, Min YH, Hong DS, et al
    Age and remission induction therapy for acute myeloid leukemia: An analysis of data from the Korean acute myeloid leukemia registry.
    PLoS One. 2021;16:e0251011.
    PubMed     Abstract available

  80. YU W, Wang W, Yu X
    Investigation of lncRNA-mRNA co-expression network in ETV6-RUNX1-positive pediatric B-cell acute lymphoblastic leukemia.
    PLoS One. 2021;16:e0253012.
    PubMed     Abstract available

  81. MOHSENI M, Kucharski C, K C RB, Nasrullah M, et al
    Therapeutic delivery of siRNA with polymeric carriers to down-regulate STAT5A expression in high-risk B-cell acute lymphoblastic leukemia (B-ALL).
    PLoS One. 2021;16:e0251719.
    PubMed     Abstract available

  82. KOVY P, Orfi Z, Bors A, Kozma A, et al
    Nucleophosmin1 and isocitrate dehydrogenase 1 and 2 as measurable residual disease markers in acute myeloid leukemia.
    PLoS One. 2021;16:e0253386.
    PubMed     Abstract available

  83. KIM SK, Goughnour PC, Lee EJ, Kim MH, et al
    Identification of drug combinations on the basis of machine learning to maximize anti-aging effects.
    PLoS One. 2021;16:e0246106.
    PubMed     Abstract available

  84. PONVILAWAN B, Kungwankiattichai S, Charoenngam N, Owattanapanich W, et al
    Is stem cell transplantation still needed for adult Philadelphia chromosome-positive acute lymphoblastic leukemia receiving tyrosine kinase inhibitors therapy?: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0253896.
    PubMed     Abstract available

  85. CATHERINET C, Passaro D, Gachet S, Medyouf H, et al
    NFAT transcription factors are essential and redundant actors for leukemia initiating potential in T-cell acute lymphoblastic leukemia.
    PLoS One. 2021;16:e0254184.
    PubMed     Abstract available

  86. KARAMI K, Akbari M, Moradi MT, Soleymani B, et al
    Survival prognostic factors in patients with acute myeloid leukemia using machine learning techniques.
    PLoS One. 2021;16:e0254976.
    PubMed     Abstract available

  87. MOUSTAFA R, Albouni T, Aziz G
    The role of procalcitonin and presepsin in the septic febrile neutropenia in acute leukemia patients.
    PLoS One. 2021;16:e0253842.
    PubMed     Abstract available

  88. FAUZI YR, Nakahata S, Chilmi S, Ichikawa T, et al
    Antitumor effects of chloroquine/hydroxychloroquine mediated by inhibition of the NF-kappaB signaling pathway through abrogation of autophagic p47 degradation in adult T-cell leukemia/lymphoma cells.
    PLoS One. 2021;16:e0256320.
    PubMed     Abstract available

  89. ZHANG W, Jang E
    Association of minimal residual disease with clinical outcomes in Philadelphia chromosome positive acute lymphoblastic leukemia in the tyrosine kinase inhibitor era: A systemic literature review and meta-analysis.
    PLoS One. 2021;16:e0256801.
    PubMed     Abstract available

  90. LONCAREVIC IF, Toepfer S, Hubold S, Klingner S, et al
    Ultra-precise quantification of mRNA targets across a broad dynamic range with nanoreactor beads.
    PLoS One. 2021;16:e0242529.
    PubMed     Abstract available

  91. VON BEEK C, Alriksson L, Palle J, Gustafson AM, et al
    Dynamin inhibition causes context-dependent cell death of leukemia and lymphoma cells.
    PLoS One. 2021;16:e0256708.
    PubMed     Abstract available

  92. GONZALEZ-RINCON J, Garcia-Vela JA, Gomez S, Fernandez-Cuevas B, et al
    Genomic mutation profile in progressive chronic lymphocytic leukemia patients prior to first-line chemoimmunotherapy with FCR and rituximab maintenance (REM).
    PLoS One. 2021;16:e0257353.
    PubMed     Abstract available

  93. OCHIAI C, Miyauchi S, Kudo Y, Naruke Y, et al
    Characterization of microRNA expression in B cells derived from Japanese black cattle naturally infected with bovine leukemia virus by deep sequencing.
    PLoS One. 2021;16:e0256588.
    PubMed     Abstract available

  94. ROSENTHAL SH, Gerasimova A, Ma C, Li HR, et al
    Analytical validation and performance characteristics of a 48-gene next-generation sequencing panel for detecting potentially actionable genomic alterations in myeloid neoplasms.
    PLoS One. 2021;16:e0243683.
    PubMed     Abstract available

  95. MATSUO S, Nishinaka-Arai Y, Kazuki Y, Oshimura M, et al
    Pluripotent stem cell model of early hematopoiesis in Down syndrome reveals quantitative effects of short-form GATA1 protein on lineage specification.
    PLoS One. 2021;16:e0247595.
    PubMed     Abstract available

  96. OLAYA-GALAN NN, Salas-Cardenas SP, Rodriguez-Sarmiento JL, Ibanez-Pinilla M, et al
    Risk factor for breast cancer development under exposure to bovine leukemia virus in Colombian women: A case-control study.
    PLoS One. 2021;16:e0257492.
    PubMed     Abstract available

  97. LUONG A, Cerignoli F, Abassi Y, Heisterkamp N, et al
    Analysis of acute lymphoblastic leukemia drug sensitivity by changes in impedance via stromal cell adherence.
    PLoS One. 2021;16:e0258140.
    PubMed     Abstract available

  98. BAO F, Zhang L, Pei X, Lian C, et al
    MiR-20a-5p functions as a potent tumor suppressor by targeting PPP6C in acute myeloid leukemia.
    PLoS One. 2021;16:e0256995.
    PubMed     Abstract available

  99. MOSQUERA ORGUEIRA A, Ferreiro Ferro R, Diaz Arias JA, Aliste Santos C, et al
    Detection of new drivers of frequent B-cell lymphoid neoplasms using an integrated analysis of whole genomes.
    PLoS One. 2021;16:e0248886.
    PubMed     Abstract available

  100. PARKER C, Zomer E, Liew D, Ayton D, et al
    Characterising experiences with acute myeloid leukaemia using an Instagram content analysis.
    PLoS One. 2021;16:e0250641.
    PubMed     Abstract available

  101. ONO R, Masuya M, Inoue N, Shinmei M, et al
    Tet1 is not required for myeloid leukemogenesis by MLL-ENL in novel mouse models.
    PLoS One. 2021;16:e0248425.
    PubMed     Abstract available

  102. MUSTAFA SS, Jamshed S, Vadamalai K, Ramsey A, et al
    Subcutaneous immunoglobulin replacement for treatment of humoral immune dysfunction in patients with chronic lymphocytic leukemia.
    PLoS One. 2021;16:e0258529.
    PubMed     Abstract available

  103. MAHESHWARI VK, Slader C, Dani N, Gkitzia C, et al
    Enabling access to molecular monitoring for chronic myeloid leukemia patients is cost effective in China.
    PLoS One. 2021;16:e0259076.
    PubMed     Abstract available

  104. SEOMUN G, Lee J, Park J
    Exposure to extremely low-frequency magnetic fields and childhood cancer: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0251628.
    PubMed     Abstract available

  105. SADATO D, Hirama C, Kaiho-Soma A, Yamaguchi A, et al
    Archival bone marrow smears are useful in targeted next-generation sequencing for diagnosing myeloid neoplasms.
    PLoS One. 2021;16:e0255257.
    PubMed     Abstract available

  106. NAGY-BALO Z, Kiss R, Demeter J, Bodor C, et al
    BCR activated CLL B cells use both CR3 (CD11b/CD18) and CR4 (CD11c/CD18) for adhesion while CR4 has a dominant role in migration towards SDF-1.
    PLoS One. 2021;16:e0254853.
    PubMed     Abstract available

  107. HOFFMANN H, Baldow C, Zerjatke T, Gottschalk A, et al
    How to predict relapse in leukemia using time series data: A comparative in silico study.
    PLoS One. 2021;16:e0256585.
    PubMed     Abstract available

  108. CARDOSO BORGES F, Ramos A, Lourenco A, Gomes da Silva M, et al
    Detailing the epidemiological and clinical characteristics of chronic lymphocytic leukaemia in Portugal-Results from a population-based cancer registry cohort study.
    PLoS One. 2021;16:e0258423.
    PubMed     Abstract available

  109. BOLOURI H, Ries R, Pardo L, Hylkema T, et al
    A B-cell developmental gene regulatory network is activated in infant AML.
    PLoS One. 2021;16:e0259197.
    PubMed     Abstract available

  110. WAN PUTEH SE, Aizuddin AN, Tumian NR, Sathar J, et al
    Health-related quality of life using EQ-5D among chronic myeloid leukaemia patients in health centres in Klang Valley, Malaysia.
    PLoS One. 2021;16:e0256804.
    PubMed     Abstract available

  111. CHOI KH, Song JH, Kwak YK, Lee JH, et al
    Analysis of PET parameters predicting response to radiotherapy for myeloid sarcoma.
    PLoS One. 2021;16:e0261550.
    PubMed     Abstract available

  112. RODRIGUEZ OL, Sharp AJ, Watson CT
    Limitations of lymphoblastoid cell lines for establishing genetic reference datasets in the immunoglobulin loci.
    PLoS One. 2021;16:e0261374.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge.